Current status of engineered T-cell therapy for synovial sarcoma.

about

Systemic Treatment for Adults with Synovial Sarcoma.

P2860

Q52667763-0F12EE34-54FA-4DC8-8691-A107CBDBB41D

P2860

Current status of engineered T-cell therapy for synovial sarcoma.

Item

http://www.wikidata.org/entity/Q38916522

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Current status of engineered T-cell therapy for synovial sarcoma.

@en

type

Item

label

Current status of engineered T-cell therapy for synovial sarcoma.

@en

prefLabel

Current status of engineered T-cell therapy for synovial sarcoma.

@en

P1476

Current status of engineered T-cell therapy for synovial sarcoma.

@en

P2093

Matthew Dallos

http://www.w3.org/2001/XMLSchema#string

Sandra P D'Angelo

http://www.w3.org/2001/XMLSchema#string

William D Tap

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook

Adoptive cell therapy for sarcoma

Fusions of the SYT and SSX genes in synovial sarcoma.

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

Mixed T cell receptor dimers harbor potentially harmful neoreactivity.

Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell Immunotherapies.

P304

1073-1080

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT-2016-0026

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27485079

http://www.w3.org/2001/XMLSchema#string

P932

5618931

http://www.w3.org/2001/XMLSchema#string

Current status of engineered T-cell therapy for synovial sarcoma.

about

P2860

P2860

Current status of engineered T-cell therapy for synovial sarcoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932